+34 679 490 537info@nanbiosis.com

Welcome to Nanbiosis – ICTS

NANBIOSIS is one of the 29 ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Council for Science Policy, Technology and Innovation (MINECO).  NANBIOSIS provides complete services for the production and characterization of nanomaterials, biomaterials and systems in biomedicine. This ICTS is integrated by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Jesus Uson Minimally Invasive Surgery Centre (JUMISC).

Platform units

NANBIOSIS is organized in five platforms distributed in Spain: Alava, Badajoz, Barcelona, Cáceres, Madrid, Valencia and Zaragoza. This infrastructure provides high technological resources and high qualified personal, and offers open services to the scientific community.

News

19 May

NANBIOSIS at CIBERDEM Annual meeting

Jesús Izco, Coordinator of NANBIOSIS, has presented NANBIOSIS-ICTS at the annual meeting of all CIBERDEM research groups, which takes place from 17 to 19 May 2017 at the Campus Hotel, on the Campus of the Universitat Autònoma de Barcelona, in Cerdanyola del Vallès. Jesús Izco has explained the opportunities offered by the ICTS NANBIOSIS as [...]

18 May

Platform2nano research by Víctor Sebastián, (Unit 9 of NANBIOSIS) awarded Marie Skłodowska-Curie

The Platform2nano research project (2012-2016) has just been awarded a second prize in the “Contribution for a better society” category, at the “Mobility Takes Research Further” conference organized by Marie Skłodowska-Curie actions (MSCA 2017) in the framework of the Presidency of Malta of the Council of the European Union. More than 195 researchers from 30 [...]

16 May

New gelatine devices that mimic the body’s activity in bone regeneration

The NanoBioCel Group, Coordinator of Unit 10 of NANBIOSIS has led the development of new scaffolds (such as burns, trauma or tumour extractions), to regenerate critical bone defects that, in addition to physical support, offers the opportunity to release growth factors temporarily replacing the bone matrix and aiding the regeneration of bone tissue. In order [...]

Next Events

SEE ALL EVENTS

About Nanbiosis

1. PLATFORM Biomolecules Production 2. PLATFORM Biomaterials and Nanomaterials Production 3. PLATFORM Tissue, Biomaterial and Surface Characterization 4. PLATFORM Bioimaging 5. PLATFORM High Performance Computing

Nanbiosis: Catalog 2015

The Spanish Strategy for Science, Technology and Innovation 2013-2020, adopted by the Council of Ministers on February 1st, 2013, includes the update of the “National Scientific and Technological Infrastructure Map (ICTS)” for the period 2013-2016 and 2016-2020.

 

The so-called singular scientific and technical infrastructures (ICTS) are large installations, resources, facilities and services, unique in its kind, that are dedicated to cutting edge and high quality research and technological development, as well as to promote exchange, transmission and preservation of knowledge, technology transfer and innovation. These are facilities of different scientific areas ranging from the life sciences to astrophysics or engineering, distributed throughout the Spanish territory.

NANBIOSIS has been recognized by the Spanish Government as one of these 29 UNIQUE existing ICTS, which are OPEN to competitive access to users of the whole research community in the public and private sector.

FAQ

What is NANBIOSIS?

It is one of the 29 UNIQUE ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Government (MINECO) which is managed by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Center for Minimally Invasive Surgery Jesus Uson (JUMISC).
NANBIOSIS coordinates 27 complementary services under a single contact point model.

Which kind of services offers the platform units?

NANBIOSIS provides a complete service that includes the design and production of biomaterials and nanomaterials and their nanoconjugates, and the characterization of these bio-/nanomaterials, tissues and medicals devices from a physic-chemical, functional, toxicological and biological (including preclinical validation) point of view, focused also on biomedical applications such as: IVDs, biosensors, regenerative medicine, drug delivery, therapeutic agents or MRI contrast agents and medical devices. A Unit dedicated to high performance computing is also included for those technological applications with large scale computational demand.

Who can use these services?

NANABIOSIS is OPEN to users of the whole research community in the public and private sector.
Order request Access protocolSurvey

Our figures

0

Units

0

Scientists linked to ICTS

0

Projects since 2008

0

Services since 2008

0

Publications since 2008

0

M€ investment

Nanbiosis